COMMUNIQUÉS West-GlobeNewswire

AveXis Enters Agreement to be Acquired by Novartis AG for $8.7 billion
09/04/2018
Novartis to acquire AveXis for $218 per share in cash AveXis’ lead product candidate, AVXS-101, expected to enhance Novartis’s position as a gene therapy and neuroscience leader Transaction expected to be completed in [...]
Menlo Therapeutics Announces Results from a Phase 2 Trial of Serlopitant for Pruritus Associated with Atopic Dermatitis
09/04/2018
Company to Host Conference Call Monday, April 9 at 4:00am PT / 7:00am ET REDWOOD CITY, Calif., April 08, 2018 (GLOBE NEWSWIRE) -- Menlo Therapeutics Inc. (NASDAQ: MNLO ), a late-stage biopharmaceutical company focused [...]
Arcturus Therapeutics Issues Statement Regarding Timing of Extraordinary General Meeting of Shareholders
08/04/2018
Postponement due to Joseph Payne’s Focus on Advancing His Personal Agenda at the Expense of Arcturus Shareholders SAN DIEGO, April 08, 2018 (GLOBE NEWSWIRE) -- Arcturus Therapeutics Ltd. (NASDAQ: ARCT ), a leading RNA [...]
Tower One Wireless Comments on Marketing Activities
07/04/2018
VANCOUVER, British Columbia, April 06, 2018 (GLOBE NEWSWIRE) -- Tower One Wireless Corp (CSE:TO) (Pink Sheets:TOWTF) (Frankfurt: 1P3N ) (“Tower One” or the “Company”) , announced today that it has been requested by the [...]
Flexion Therapeutics Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
06/04/2018
BURLINGTON, Mass., April 06, 2018 (GLOBE NEWSWIRE) -- Flexion Therapeutics, Inc. (Nasdaq: FLXN ) today announced a grant of inducement stock options to four new employees for an aggregate of 12,300 shares of common [...]
Inspire Medical Systems, Inc. Announces Filing of Registration Statement for Proposed Initial Public Offering
06/04/2018
MINNEAPOLIS, April 06, 2018 (GLOBE NEWSWIRE) -- Inspire Medical Systems, Inc. ("Inspire”), a medical technology company focused on the development and commercialization of innovative and minimally invasive solutions for [...]
HealthEquity Appoints Angelique Hill as EVP of Operations
06/04/2018
DRAPER, Utah, April 06, 2018 (GLOBE NEWSWIRE) -- HealthEquity, Inc. (NASDAQ: HQY ) (“HealthEquity” or the “Company”), the nation’s largest health savings account (HSA) non-bank custodian, today announced that it has [...]
NewLink Genetics Announces Review of Clinical Programs
06/04/2018
AMES, Iowa, April 06, 2018 (GLOBE NEWSWIRE) -- NewLink Genetics Corporation (NASDAQ: NLNK ) today announced a review of its clinical programs. This morning’s announcement by Incyte and Merck on the ECHO-301 trial for [...]
VALNEVA : Déclaration d'actions et de droits de vote Mars 2018
06/04/2018
VALNEVA Déclaration d'actions et de droits de vote - MARS 2018 Dénomination sociale : VALNEVA Adresse du siège social : World Trade Center Lyon - Tour Oxygène, 10-12 Boulevard Marius Vivier Merle, 69003 Lyon Marché [...]
MDxHealth Shareholder Transparency Declaration
06/04/2018
Press release Regulated information 6 April 2018, 5.45 p.m. CET MDxHealth Shareholder Transparency Declaration HERSTAL, BELGIUM and IRVINE, CA - April 6, 2018 - MDxHealth SA (Euronext Brussels: MDXH) ("MDxHealth" or the [...]
MDxHealth: Déclaration de Transparence d'un Actionnaire
06/04/2018
C ommuniqué de presse Information réglementée 6 avril 2018, 17h45 HEC MDxHealth: Déclaration de Transparence d'un Actionnaire IRVINE, CA, et HERSTAL (BELGIQUE) - le 6 avril 2018 - MDxHealth SA (Euronext Brussels: MDXH [...]
IBA SA : 2018 AGE - AGO CONVENING NOTICE
06/04/2018
Cher Actionnaire, Conc e r n e : Assemblée Générale Extraordinaire du 9 mai 2018 à 9h30 et Assemblée Générale Ordinaire et Spéciale du 9 mai 2018 à 10h00 Nous avons l'honneur de vous convoquer à une Assemblée Générale [...]
Teligent, Inc. Announces FDA Approval of Ciclopirox Shampoo, 1%
06/04/2018
BUENA, N.J., April 06, 2018 (GLOBE NEWSWIRE) -- Teligent, Inc. (NASDAQ: TLGT ), a New Jersey-based specialty generic pharmaceutical company, today announced it has received approval of the Company’s abbreviated new drug [...]
Summit Therapeutics plc : Block listing Interim Review
06/04/2018
BLOCK LISTING SIX MONTHLY RETURN (Note: Italicised terms have the same meaning as given in the Listing Rules.) Date: 6 April 2018 Name of applicant : Summit Therapeutics plc Name of scheme: 2005 EMI Scheme Period of [...]
EyeGate Completes Enrollment and Receives Milestone Payment for Confirmatory Phase 3 Clinical Study of EGP-437 in Anterior Uveitis
06/04/2018
Top line Data expected in Q3 2018 WALTHAM, Mass., April 06, 2018 (GLOBE NEWSWIRE) -- EyeGate Pharmaceuticals, Inc. (NASDAQ: EYEG ) (“EyeGate” or the “Company”), today announced completion of patient enrollment for the [...]
BioSig Technologies to Present at the MicroCap Conference
06/04/2018
Santa Monica, CA, April 06, 2018 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (OTCQB: BSGM), a medical device company developing a proprietary biomedical signal processing platform designed to address an unmet [...]
Tyme and JAF Announce Sarcoma Treatment Collaboration
06/04/2018
NEW YORK, April 06, 2018 (GLOBE NEWSWIRE) -- Tyme Technologies, Inc. (NASDAQ: TYME ), a clinical-stage oncology company, today announced that it is collaborating with The Joseph Ahmed Foundation (“JAF”) to provide [...]
Adaptimmune to Present Two Posters at the Upcoming American Association for Cancer Research (AACR) Annual Meeting
06/04/2018
PHILADELPHIA, Pa. and OXFORD, U.K., April 06, 2018 (GLOBE NEWSWIRE) -- Adaptimmune Therapeutics plc (Nasdaq: ADAP ), a leader in T-cell therapy to treat cancer, will present two posters summarizing preclinical research [...]
BioCorRx Provides Business Update for the Full Year Ended 2017
06/04/2018
ANAHEIM, CA, April 06, 2018 (GLOBE NEWSWIRE) -- BioCorRx Inc. (OTCQB: BICX) (the "Company") , a developer and provider of advanced solutions in the treatment of alcohol and opioid addictions, today provided a business [...]

Pages